Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

ClinicalTrials.gov ID: NCT03623321

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03623321. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 20, 2026, 3:41 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52-Week Open-label Extension Study of Pimavanserin in Adult and Elderly Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the long-term safety and tolerability of pimavanserin in adult and elderly subjects with neuropsychiatric symptoms related to neurodegenerative disease exposed to open-label pimavanserin for up to 52 weeks.

Study identification

NCT ID
NCT03623321
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ACADIA Pharmaceuticals Inc.
Industry
Enrollment
595 participants

Conditions and interventions

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 17, 2018 (Actual)
Primary completion
May 5, 2023 (Actual)
Completion
May 5, 2023 (Actual)
Last update posted
Dec 20, 2024

2018 – 2023

United States locations

U.S. sites
17
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
Cognitive Clinical Trials Gilbert Arizona 85296 —
ATP Clinical Research, Inc. Costa Mesa California 92626 —
Syrentis Clinical Research Santa Ana California 92705 —
Indago Research & Health Center Inc Hialeah Florida 33012 —
Reliable Clinical Research, LLC Hialeah Florida 33012 —
Premier Clinical Research Institute, Inc. Miami Florida 33122 —
Global Medical Institutes Miami Florida 33125 —
Future Care Solution, LLC Miami Florida 33165 —
MediClear Medical & Research Center, Inc. Miami Florida 33165 —
Novel Clinical Research LLC Miami Florida 33186 —
Laszlo J Mate, MD, PA North Palm Beach Florida 33408 —
Synexus Clinical Research US, Inc. The Villages Florida 32162 —
The NeuroCognitive Institute Mount Arlington New Jersey 07856 —
UNC Hospital Chapel Hill North Carolina 27599 —
Insight Clinical Trials LLC Shaker Heights Ohio 44122 —
Suburban Research Associates Media Pennsylvania 19063 —
Central for Biomedical Research, LLC Knoxville Tennessee 37909 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03623321, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 20, 2024 · Synced Nov 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.